| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/09/2002 | EP1169470A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
| 01/09/2002 | EP1169351A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity |
| 01/09/2002 | EP1169048A2 Hyaluronic acid mimics and methods related thereto |
| 01/09/2002 | EP0728146B1 Conotoxin peptides |
| 01/09/2002 | CN1330713A Zinc finger binding domains for GNN |
| 01/09/2002 | CN1330675A Polyamide chains of precise length, methods to manufacture them and their conjugates with protein |
| 01/09/2002 | CN1330550A Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2002 | CN1330077A Endothelin antegon |
| 01/09/2002 | CN1330076A Endothelin antagon |
| 01/09/2002 | CN1330075A Endothelin antagon |
| 01/09/2002 | CN1077439C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/08/2002 | US6337317 Amino acid sequence peptides as microbiocides |
| 01/08/2002 | US6337316 Pharmaceutical compositions thereof, and methods of using same |
| 01/08/2002 | CA2246222C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/08/2002 | CA2042001C Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors |
| 01/03/2002 | WO2002000839A2 Statement as to federally sponsored research |
| 01/03/2002 | WO2002000688A1 Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient |
| 01/03/2002 | WO2002000687A2 Antimicrobial peptides and methods of use thereof |
| 01/03/2002 | WO2002000265A1 Intramolecularly-quenched near infrared fluorescent probes |
| 01/03/2002 | WO2001049713A3 Stabilizing peptides, polypeptides and antibodies which include them |
| 01/03/2002 | US20020001840 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 01/03/2002 | US20020001566 Pharmaceuticals for the imaging of angiogenic disorders |
| 01/03/2002 | US20020001332 Mounting arrangement for auxiliary burner or lance |
| 01/03/2002 | CA2415236A1 Novispirins: antimicrobial peptides |
| 01/02/2002 | EP1167526A1 IgE-dependent histamine-releasing factor(HRF)receptor, HRF-binding peptides and nucleic acids encoding the same, and uses thereof |
| 01/02/2002 | EP1167522A1 Method for screening biomolecule activity regulator |
| 01/02/2002 | EP1167382A1 Influenza virus hemagglutinin-binding peptides |
| 01/02/2002 | EP1165616A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 01/02/2002 | EP1165613A1 Melanocortin receptor ligands |
| 01/02/2002 | EP1165610A1 Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same |
| 01/02/2002 | EP1165609A2 Human beta-secretase enzyme, inhibitors and their compositions and uses |
| 01/02/2002 | EP1165541A1 Dimeric compounds and as inhibitors of neuraminidase |
| 01/02/2002 | EP1165490A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 01/02/2002 | EP1165120A2 A uro-genital condition treatment system |
| 01/02/2002 | EP1165112A1 Modulators of polysaccharides and uses thereof |
| 01/02/2002 | EP1165099A2 Methods for limiting scar and adhesion formation |
| 01/02/2002 | EP0833843B1 Depigmenting activity of agouti signal protein and peptides thereof |
| 01/02/2002 | EP0722457B1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications |
| 01/02/2002 | CN1329665A Gluocoamylases with N-terminal extensions |
| 01/01/2002 | US6335320 Method of treating fibrotic conditions |
| 01/01/2002 | US6335318 Antimicrobial theta defensins and methods of using same |
| 01/01/2002 | US6335195 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/01/2002 | US6335176 Reagent is succinimidyl moiety linked to kinase substrate; can be linked to free primary or secondary amine in compound to be phosphorylated |
| 01/01/2002 | US6335158 Immunologically active peptide of given amino acid sequence which binds antibodies against retroviruses of the hiv type; diagnostic kits |
| 01/01/2002 | US6334996 Radiolabels for targeting specific diagnostic pharmaceuticals |
| 01/01/2002 | CA2097192C Bombesin antagonists |
| 01/01/2002 | CA2068327C Polypeptide and anti-hiv drug prepared therefrom |
| 01/01/2002 | CA2026376C Anticoagulant peptides |
| 12/27/2001 | WO2001098540A2 Recombination modulators and methods for their production and use |
| 12/27/2001 | WO2001098367A2 Neuroactive peptides for treatment of hypoxia and related conditions |
| 12/27/2001 | WO2001098366A2 Enterokinase cleavage sequences and their use |
| 12/27/2001 | WO2001098364A2 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 12/27/2001 | WO2001098362A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | WO2001098325A1 Methods for treating and preventing alopecia |
| 12/27/2001 | WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/27/2001 | WO2001097861A2 Vitronectin receptor antagonist pharmaceuticals |
| 12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | WO2001036453A3 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 12/27/2001 | US20010056179 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity |
| 12/27/2001 | US20010056178 Inhibitors of protein synthesis, cell growth and tumorigenesis, and enhancers of apoptosis |
| 12/27/2001 | CA2713965A1 Glycopeptide phosphonate derivatives |
| 12/27/2001 | CA2413974A1 Neuroactive peptides for treatment of hypoxia and related conditions |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2412849A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 12/27/2001 | CA2412513A1 Modulators of recombination and methods for producing and using the same |
| 12/27/2001 | CA2412011A1 Chemically-modified antimicrobial peptides, compositions and methods of production and use |
| 12/27/2001 | CA2411857A1 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 12/27/2001 | CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 12/27/2001 | CA2408630A1 Novel enterokinase cleavage sequences |
| 12/26/2001 | CN1328568A Peptide derivative |
| 12/25/2001 | US6333395 Exhibit anti-membrane fusion capability, antiviral activity, such as the ability to inhibit hiv transmission to uninfected cells |
| 12/25/2001 | US6333308 Cyclic peptide derivatives |
| 12/25/2001 | US6333307 Compounds and method for modulating neurite outgrowth |
| 12/25/2001 | US6333031 Receptor derived peptides as modulators of receptor activity |
| 12/25/2001 | CA2099497C Peptides with anticoagulant activity |
| 12/20/2001 | WO2001096368A2 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/20/2001 | WO2001096364A2 Peptides that stimulate cell survival and axon regeneration |
| 12/20/2001 | WO2001095785A2 Modulation of immune response and methods based thereon |
| 12/20/2001 | WO2001066567A3 Design, synthesis and use of affinity ligands |
| 12/20/2001 | WO2001055725A3 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 12/20/2001 | WO2001044505A3 Methods and kits for discovery of rna-binding antimicrobials |
| 12/20/2001 | US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct. |
| 12/20/2001 | CA2410604A1 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 12/19/2001 | EP1164143A1 Process for preparing octreotide and derivatives thereof |
| 12/19/2001 | EP1163264A1 Novel lhrh antagonists with improved solubility characteristics |
| 12/19/2001 | EP1163260A1 Process for partitioning of proteins |
| 12/19/2001 | EP1162991A1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis |
| 12/19/2001 | EP1162880A1 Human sperm surface antigens |
| 12/19/2001 | EP0935605A4 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 12/19/2001 | EP0528820B2 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase |
| 12/19/2001 | CN1327450A Regulatory/unfolding peptides of ezrin |
| 12/19/2001 | CN1327388A Modified antibodies of induced anti-idiotype reaction enhancement |
| 12/18/2001 | US6331521 Beta-1,3-glucan synthase inhibitors; pneumocystis pneumonia infection treatment; fungicides |
| 12/18/2001 | US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein |
| 12/18/2001 | US6331299 Method for treatment of cancer and infectious disease and compositions useful in same |
| 12/13/2001 | WO2001094621A1 Screening method for modulators of suv39h2-methyltransferase |
| 12/13/2001 | WO2001094620A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
| 12/13/2001 | WO2001094547A2 Molecular delivery vehicle for delivery of selected compounds to targets |
| 12/13/2001 | WO2001094411A1 Peptides modulating protease activated receptors and methods of using same |
| 12/13/2001 | WO2001094382A1 Oligopeptides |